Bychkovsky, B., Rana, H. Q., Ademuyiwa, F., Plichta, J., Anderson, K., Nogueira-Rodrigues, A., … Dizon, D. S. (2022). Call for action: expanding global access to hereditary cancer genetic testing. Lancet Oncol, 23(9), 1124–1126. https://doi.org/10.1016/S1470-2045(22)00378-3

Bychkovsky, Brittany, Huma Q. Rana, Foluso Ademuyiwa, Jennifer Plichta, Karen Anderson, Angélica Nogueira-Rodrigues, Cesar A. Santa-Maria, et al. “Call for action: expanding global access to hereditary cancer genetic testing.” Lancet Oncol 23, no. 9 (September 2022): 1124–26. https://doi.org/10.1016/S1470-2045(22)00378-3.

Bychkovsky B, Rana HQ, Ademuyiwa F, Plichta J, Anderson K, Nogueira-Rodrigues A, et al. Call for action: expanding global access to hereditary cancer genetic testing. Lancet Oncol. 2022 Sep;23(9):1124–6.

Bychkovsky, Brittany, et al. “Call for action: expanding global access to hereditary cancer genetic testing.” Lancet Oncol, vol. 23, no. 9, Sept. 2022, pp. 1124–26. Pubmed, doi:10.1016/S1470-2045(22)00378-3.

Bychkovsky B, Rana HQ, Ademuyiwa F, Plichta J, Anderson K, Nogueira-Rodrigues A, Santa-Maria CA, Coffman LG, Marquez C, Das A, Taghian A, Koeller DR, Sandoval RL, Park BH, Dizon DS. Call for action: expanding global access to hereditary cancer genetic testing. Lancet Oncol. 2022 Sep;23(9):1124–1126.